London & Capital Glb Eq Opps X USD Acc |
Performance History | 30/09/2024 |
Growth of 1,000 (EUR) |
Fund | - | - | - | 29.0 | 8.9 | |
+/-Cat | - | - | - | 10.2 | -5.0 | |
+/-Idx | - | - | - | 3.7 | -10.2 | |
Category: Global Large-Cap Growth Equity | ||||||
Benchmarks: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 16/10/2024 | USD 138.73 | |
Day Change | -0.87% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | IE0007OTC3H0 | |
Fund Size (Mil) 16/10/2024 | USD 45.39 | |
Share Class Size (Mil) 16/10/2024 | USD 25.30 | |
Max Initial Charge | - | |
Ongoing Charge 01/01/2023 | 0.67% |
Investment Objective: London & Capital Glb Eq Opps X USD Acc |
To seek to provide long-term capital growth through investments in global equities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
- - | ||
Inception Date 25/05/2022 |
Advertisement |
Benchmarks | |
Fund Benchmark | Morningstar Benchmark |
- | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for London & Capital Glb Eq Opps X USD Acc | 31/07/2024 |
|
|
Top 5 Holdings | Sector | % |
Alphabet Inc Class C | Communication Services | 7.88 |
Cadence Design Systems Inc | Technology | 6.36 |
Repligen Corp | Healthcare | 5.82 |
Microsoft Corp | Technology | 5.80 |
Intuitive Surgical Inc | Healthcare | 5.19 |
Increase Decrease New since last portfolio | ||
London & Capital Glb Eq Opps X USD Acc |